Evidence map›Paper›PMID 35564494›Full record

ReviewInternational journal of environmental research and public health2022

Telemedicine in the COVID-19 Era: A Narrative Review Based on Current Evidence.

Giulio Nittari, Demetris Savva, Daniele Tomassoni, Seyed Khosrow Tayebati, Francesco Amenta

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 2 pooled it
19.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 2 syntheses or guidelines pooled it, 99 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Effect of Remote and Virtual Technology on Home Dialysis.Clinical journal of the American Society of Nephrology : CJASN · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Giulio NittariSchool of Pharmaceutical Sciences and Health Products, University of Camerino, Via Madonna delle Carceri, 9, 62032 Camerino, MC, Italy.ORCID 0000-0002-7918-8442
Demetris SavvaPlastic Reconstructive and Aesthetic Surgery, Nicosia General Hospital, Nicosia-Limassol Old Road 215, Nicosia 2029, Cyprus.
Daniele TomassoniSchool of Biosciences and Veterinary Medicine, University of Camerino, Via Gentile III da Varano, 62032 Camerino, MC, Italy.ORCID 0000-0001-9062-3305
Seyed Khosrow TayebatiSchool of Pharmaceutical Sciences and Health Products, University of Camerino, Via Madonna delle Carceri, 9, 62032 Camerino, MC, Italy.ORCID 0000-0002-7219-6917
Francesco AmentaSchool of Pharmaceutical Sciences and Health Products, University of Camerino, Via Madonna delle Carceri, 9, 62032 Camerino, MC, Italy.
Università di Camerino · ITNicosia General Hospital · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

During the recent COVID-19 pandemic, healthcare providers have been encouraged to increase their use of telemedicine and to adopt telemedicine platforms for the majority of their clients who have chronic illnesses. Due to the outbreak itself, almost all countries worldwide were placed under emergency lockdowns. In this paper, we reviewed the literature regarding the use of telemedicine during the COVID-19 pandemic. Consequentially, we identified the adoption of telemedicine in various countries worldwide and evaluated their future steps in order to increase the adoption of e-health technologies. As a result of COVID-19, the e-health agenda, especially telemedicine, has been accelerated in several countries. COVID-19 is affecting individuals' daily lives and has created major difficulties in the management of healthcare facilities for both infected and non-infected patients. A large portion of the rapid increase in the use of telemedicine can be attributed to evidence from previous pandemics as well as progress made by the field in response to COVID-19, especially in industrialized countries. A lack of effective treatment, large numbers of unvaccinated individuals, as well as social distancing and lockdown measures suggest telemedicine is the safest and most appropriate way of working with patients and doctors. In spite of this willingness, a large number of barriers need to be overcome in order for the telemedicine system to function properly and effectively throughout countries. In order for telemedicine to be sustainable and beneficial beyond the pandemic, several technical, educational, infrastructure, legal, and economic issues must be addressed and solved.

Indexed as

COVID-19TelemedicineCommunicable Disease ControlHumansPandemicsSARS-CoV-2COVID-19e-healthpublic health emergencyremote treatmentsocial distancetelemedicine

Identifiers

PMID35564494
PMCPMC9105428
OpenAlexW4224214613

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.